Delayed apoptosis by neutrophils from COPD patients is associated with altered bak, bcl-xl, and mcl-1 mRNA expression

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Zhang, Jisong ^b   He, Jian ^a   Xia, Jingwen ^a   Chen, Zhen ^a   Chen, Xiaodong ^a  

^a FUDAN UNIVERSITY   (China)

^b Hangzhou Xiasha Hospital   (China)

Author keywords

Apoptosis; Bcl 2; Chronic obstructive pulmonary disease; Lung function; Neutrophils

Indexed keywords

BAK1 PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; MESSENGER RNA; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL X;

AGED; APOPTOSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CHI SQUARE DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LEUKOCYTE ACTIVATION; LUNG; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TIME; VITAL CAPACITY;

AGED; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; CASE-CONTROL STUDIES; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION REGULATION; HUMANS; LUNG; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TIME FACTORS; VITAL CAPACITY;

EID: 84861969819     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-65     Document Type: Article

References (25)

1. Colby J, Goldman M. Update on the management of COPD. Conn Med 2009, 73:217-221.
2. Plataki M, Tzortzaki E, Rytila P, Demosthenes M, Koutsopoulos A, Siafakas NM. Apoptotic mechanisms in the pathogenesis of COPD. Int J COPD 2006, 1:161-171.
3. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999, 160:S5-S11.
4. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998, 53:129-136. 10.1136/thx.53.2.129, 1758710, 9624299.
5. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:S17-S20.
6. Cosio Piqueras MG, Cosio MG. Diseases of the airways in chronic obstructive pulmonary disease. Eur Respir J 2001, 34:S41-S49.
7. Turlej RK, Fiévez L, Sandersen CF, Dogné S, Kirschvink N, Lekeux P, Bureau F. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signaling pathway. Thorax 2001, 56:696-702. 10.1136/thorax.56.9.696, 1746130, 11514690.
8. Pletz MW, Ioanas M, de Roux A, Burkhardt O, Lode H. Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J 2004, 23:532-537. 10.1183/09031936.04.00089004, 15083750.
9. Noguera A, Sala E, Pons AR, Iglesias J, MacNee W, Agustí AG. Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD. Chest 2004, 125:1837-1842. 10.1378/chest.125.5.1837, 15136398.
10. Makris D, Vrekoussis T, Izoldi M, Alexandra K, Katerina D, Dimitris T, Michalis A, Tzortzaki E, Siafakas NM, Tzanakis N. Increased apoptosis of neutrophils in induced sputum of COPD patients. Respir Med 2009, 103:1130-1135. 10.1016/j.rmed.2009.03.002, 19329291.
11. Schmidt-Ioanas M, Pletz MW, de Roux A, Lode H. Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines. Respir Med 2006, 100:639-647. 10.1016/j.rmed.2005.08.011, 16199149.
12. Brown V, Elborn JS, Bradley J, Ennis M. Dysregulated apoptosis and NFκB expression in COPD subjects. Respiratory Res 2009, 18:24.
13. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004, 101(41):14895-14900. 10.1073/pnas.0401168101, 522001, 15469929.
14. Akgul C, Moulding DA, Edwards SW. Molecular control of neutrophil apoptosis. FEBS Lett 2001, 487:318-322. 10.1016/S0014-5793(00)02324-3, 11163351.
15. Moulding DA, Akgul C, Derouet M, White MR, Edwards SW. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. Leukoc Biol 2001, 70:783-792.
16. Cowburn AS, Cadwallader KA, Reed BJ, Farahi N, Chilvers ER. Role of PI3-kinase-dependent Bad phosphorylation and altered transcription in cytokine-mediated neutrophil survival. Blood 2002, 100:2607-2616. 10.1182/blood-2001-11-0122, 12239175.
17. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985, 119:101-110. 1888083, 2984939.
18. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserune expression on early apoptosis cells using fluorescein labeled Annexin V. I Immunol Methods 1995, 184:39-51.
19. Whelan JA, Russell NB, Whelan MA. A method for the absolute quantification of cDNA using real-time PCR. J Immunol Methods 2003, 278:261-269. 10.1016/S0022-1759(03)00223-0, 12957413.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2T-ΔΔC method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
21. Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 2000, 7:1182-1191. 10.1038/sj.cdd.4400781, 11175255.
22. Van Raam BJ, Verhoeven AJ, Kuijpers TW. Mitochondria in neutrophil apoptosis. Int J Hematol 2006, 84:199-204. 10.1532/IJH97.06131, 17050191.
23. Härter L, Mica L, Stocker R, Trentz O, Keel M. Mcl-1 correlates with reduced apoptosis in neutrophils from patients with sepsis. J Am Coll Surg 2003, 197:964-973. 10.1016/j.jamcollsurg.2003.07.008, 14644285.
24. Mayer AS, Newman LS. Genetic and environmental modulation of chronic obstructive pulmonary disease. Respir Physiol 2001, 128:3-11. 10.1016/S0034-5687(01)00258-4, 11535256.
25. Sata M, Takabatake N, Inoue S, Shibata Y, Abe S, Machiya J, Wada T, Ji G, Kido T, Matsuura T, Muramatsu MA, Kubota I. Intronic single-nucleotide polymorphisms in Bcl-2 are associated with chronic obstructive pulmonary disease severity. Respirology 2007, 12:34-41. 10.1111/j.1440-1843.2006.00959.x, 17207023.